WASHINGTON -Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.
WASHINGTON -Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.